Breaking News Instant updates and real-time market news.

AMRI

Albany Molecular

$17.08

-0.26 (-1.50%)

, SHPG

Shire

$174.84

-0.39 (-0.22%)

07:46
11/29/16
11/29
07:46
11/29/16
07:46

AMRI announces supply agreement with Shire

AMRI (AMRI) announced that it has entered into a multi-year supply agreement for an undisclosed product with Shire US Manufacturing, which product has been in AMRI's portfolio through the required stages of development. Shire (SHPG) is a leading global biotechnology company focused on developing and marketing innovative medicines for patients with rare diseases and other highly specialized conditions. The terms of the agreement are confidential. This is the second such multi-year agreement between AMRI and Shire, as AMRI has also been supplying a key neuroscience product to Shire.

AMRI

Albany Molecular

$17.08

-0.26 (-1.50%)

SHPG

Shire

$174.84

-0.39 (-0.22%)

  • 03

    Dec

AMRI Albany Molecular
$17.08

-0.26 (-1.50%)

SHPG Shire
$174.84

-0.39 (-0.22%)

11/01/16
BTIG
11/01/16
NO CHANGE
Target $242
BTIG
Buy
Shire's recent weakness overdone, says BTIG
BTIG analyst Timothy Chiang believes the recent selloff in Shire is overdone and that weakness in the Hematology segment was impacted by the timing of large orders. The analyst maintains his Buy rating and $242 price target on Shire shares.
11/02/16
LEER
11/02/16
NO CHANGE
Target $198
LEER
Outperform
Shire price target lowered to $198 from $234 at Leerink
Following a modest Q3 miss, Leerink analyst Jason Gerberry lowered his price target for Shire to $198 from $234 to reflect a more conservative outlook on key franchises due to out-year competitive pressures. The analyst reiterates an Outperform rating on the stock as he believes concerns around pricing look overdone and shares are attractively valued.
11/09/16
SBSH
11/09/16
NO CHANGE
SBSH
Citi sees Healthcare 'relief rally' after Trump win
Citi analyst Andrew Baum expects a "'relief rally" to drive near-term sector outperformance for names in the Healthcare space given the "inability of the Democrats to attain the Presidency, the House or Congress." Longer term, however, the analyst still sees "significant continued legislative risk" for pharma reimbursement. Baum prefers GlaxoSmithKline (GSK), AstraZeneca (AZN), Shire (SHPG) and Roche (RHHBY) among European majors and Bristol-Myers (BMY) and Eli Lilly (LLY) in the U.S.
11/14/16
JPMS
11/14/16
NO CHANGE
JPMS
JPMorgan says Merrimack could fit as target for Shire
JPMorgan analyst Anupam Rama believes Merrimack Pharmaceuticals (MACK) could fit as a potential target for Shire (SHPG). The $1B deal size would be manageable, Rama tells investors in a research note after Ben Harrington's Betaville blog, citing sources, reported Friday that Shire is among the companies participating in Merrimack's strategic review process. Assuming a 40% premium to the intraday Merrimack share price, the deal would be 1% accretive in 2019 and 2% accretive in 2020, Rama estimates.

TODAY'S FREE FLY STORIES

VRX

Valeant

$16.84

-0.24 (-1.41%)

15:05
06/27/17
06/27
15:05
06/27/17
15:05
Recommendations
Valeant analyst commentary  »

Several Valeant products…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

CAMP

CalAmp

$19.62

-0.5 (-2.49%)

15:04
06/27/17
06/27
15:04
06/27/17
15:04
Options
CalAmp options imply 15.1% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

OSUR

OraSure

$15.72

0.17 (1.09%)

14:59
06/27/17
06/27
14:59
06/27/17
14:59
Recommendations
OraSure analyst commentary  »

OraSure price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

GG

Goldcorp

$13.43

-0.24 (-1.76%)

, XRA

Exeter Resource

14:56
06/27/17
06/27
14:56
06/27/17
14:56
Hot Stocks
Goldcorp agrees to acquire all Exeter Resource shares it does not already own »

Goldcorp (GG) announced…

GG

Goldcorp

$13.43

-0.24 (-1.76%)

XRA

Exeter Resource

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

KBH

KB Home

$23.04

0.26 (1.14%)

14:49
06/27/17
06/27
14:49
06/27/17
14:49
Options
KB Home options imply 6.7% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

CMCSA

Comcast

$39.59

0.09 (0.23%)

, CMCSK

Comcast

14:41
06/27/17
06/27
14:41
06/27/17
14:41
Periodicals
NBC Sports to offer Premier League streaming package, Recode says »

NBCUniversal's NBC…

CMCSA

Comcast

$39.59

0.09 (0.23%)

CMCSK

Comcast

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

CF

CF Industries

$27.08

-0.33 (-1.20%)

14:30
06/27/17
06/27
14:30
06/27/17
14:30
Options
CF sees call buying »

CF sees call buying. The…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:30
06/27/17
06/27
14:30
06/27/17
14:30
General news
Yellen reiterated the Fed's commitment to price stability »

Yellen reiterated the…

MLHR

Herman Miller

$29.50

0.1 (0.34%)

14:27
06/27/17
06/27
14:27
06/27/17
14:27
Initiation
Herman Miller initiated  »

Herman Miller initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jul

DECK

Deckers Brands

$67.76

0.82 (1.23%)

14:26
06/27/17
06/27
14:26
06/27/17
14:26
Hot Stocks
Marcato confirms letter to Deckers, says prepared to seek board ouster »

Marcato Capital, which…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAR

Avis Budget

$27.67

3.43 (14.15%)

14:25
06/27/17
06/27
14:25
06/27/17
14:25
Options
Avis Budget call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DECK

Deckers Brands

$67.54

0.6018 (0.90%)

14:20
06/27/17
06/27
14:20
06/27/17
14:20
Periodicals
Marcato threatens proxy fight at Deckers Brands, CNBC reports »

CNBC's Leslie…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

14:17
06/27/17
06/27
14:17
06/27/17
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$242.12

-1.1728 (-0.48%)

, SPX

S&P 500

14:16
06/27/17
06/27
14:16
06/27/17
14:16
Technical Analysis
Technical View: S&P 500 takes out channel low »

The S&P 500 (SPX) has…

SPY

SPDR S&P 500 ETF Trust

$242.12

-1.1728 (-0.48%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DECK

Deckers Brands

$67.53

0.59 (0.88%)

14:16
06/27/17
06/27
14:16
06/27/17
14:16
Periodicals
Marcato threatens proxy fight at Deckers Brands, CNBC reports 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

14:16
06/27/17
06/27
14:16
06/27/17
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZN

AstraZeneca

$34.59

-0.565 (-1.61%)

14:15
06/27/17
06/27
14:15
06/27/17
14:15
Options
AstraZeneca put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

14:10
06/27/17
06/27
14:10
06/27/17
14:10
General news
Treasury Action: Fed chair Yellen hasn't said anything on the policy path »

Treasury Action: Fed…

AIII

ACRE Realty Investors

14:09
06/27/17
06/27
14:09
06/27/17
14:09
Hot Stocks
Breaking Hot Stocks news story on ACRE Realty Investors »

ACRE Realty Investors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TDG

TransDigm

$264.99

-3.26 (-1.22%)

14:05
06/27/17
06/27
14:05
06/27/17
14:05
Hot Stocks
TransDigm slips after Capitol Forum says DLA confirms active probe »

Shares of TransDigm are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENFC

Entegra Financial

$23.40

0.25 (1.08%)

14:04
06/27/17
06/27
14:04
06/27/17
14:04
Downgrade
Entegra Financial rating change  »

Entegra Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIII

ACRE Realty Investors

14:01
06/27/17
06/27
14:01
06/27/17
14:01
Hot Stocks
ACRE Realty Investors announces board approval of dissolution »

ACRE Realty Investors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$37.72

-0.4349 (-1.14%)

13:55
06/27/17
06/27
13:55
06/27/17
13:55
Options
AT&T put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:55
06/27/17
06/27
13:55
06/27/17
13:55
General news
FX Action: USD-JPY »

FX Action: USD-JPY topped…

13:54
06/27/17
06/27
13:54
06/27/17
13:54
General news
Senate GOP leaders delay healthcare vote until after July 4 recess, AP says 

Reference Link

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.